Access Statistics for Anirban Basu

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Choosing Wisely: Evaluating Latent Factor Models in the Presence of a Contaminated Instrumental Variable with Varying Strength 0 0 0 1 0 4 12 36
Comparing 2SLS vs 2SRI for Binary Outcomes and Binary Exposures 0 0 1 48 4 10 54 139
Do For-Profit Hospitals Cream-Skim Patients? Evidence from Inpatient Psychiatric Care in California 0 0 3 15 0 3 20 37
Dynamic Efficiency and Pricing of Innovations with Insurance: The Case for Gene Therapies 0 0 0 5 0 7 17 32
Economics of Individualization in Comparative Effectiveness Research and a Basis for a Patient-Centered Health Care 0 0 1 48 0 2 25 199
Estimating Lifetime or Episode-of-illness Costs 0 0 2 110 0 1 12 297
Estimating Person-Centered Treatment (PeT) Effects Using Instrumental Variables 0 0 0 52 1 1 6 160
Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality 0 0 0 18 0 8 18 116
Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality 0 0 0 39 1 6 13 203
Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data 0 0 1 47 0 2 12 173
Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data 0 1 1 291 0 5 13 885
Hidden Figures: Uncovering Quantities Behind Zeros with Econometrics 0 0 0 16 0 3 9 30
Impact of Rural and Urban Hospital Closures on Inpatient Mortality 0 0 0 86 4 9 23 179
Political Polarization, Anticipated Health Insurance Uptake and Individual Mandate: A view from the Washington State 0 0 0 16 0 5 8 45
Price Elasticities of Pharmaceuticals in a Value-Based-Formulary Setting 0 0 1 63 1 6 21 115
Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion 0 1 1 51 0 5 13 47
Service-level Selection: Strategic Risk Selection in Medicare Advantage in Response to Risk Adjustment 0 0 0 7 0 4 30 80
The Impact of Comparative Effectiveness Research on Health and Health Care Spending 0 0 0 57 1 4 11 240
The New Prescription Drug Paradox: Pipeline Pressure and Rising Prices 0 0 0 73 1 4 13 115
The Role of Physician Altruism in the Physician-Industry Relationship 1 1 3 13 1 6 16 31
The Roles of Cognitive and Non-Cognitive Skills in Moderating the Effects of Mixed-Ability Schools on Long-Term Health 0 0 0 42 1 2 7 108
The impact of Medicare Part D on Medicare-Medicaid Dual-eligible Beneficiaries' Prescription Utilization and Expenditures 0 0 0 42 0 1 9 171
Understanding Algorithmic Discrimination in Health Economics Through the Lens of Measurement Errors 0 0 0 21 0 2 12 62
Use of Propensity Scores in Non-Linear Response Models: The Case for Health Care Expenditures 0 0 0 54 0 5 11 229
Use of instrumental variables in the presence of heterogeneity and self-selection: An application in breast cancer patients 0 2 3 486 0 6 18 1,360
Use of propensity scores in non-linear response models: The case for health care expenditures 0 0 1 147 0 4 14 534
Welfare Implications of Learning Through Solicitation versus Diversification in Health Care 0 0 0 36 1 3 10 65
Total Working Papers 1 5 18 1,884 16 118 427 5,688


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
CAN WE MAKE SMART CHOICES BETWEEN OLS AND CONTAMINATED IV METHODS? 0 0 0 3 0 1 6 30
Comparing alternative models: log vs Cox proportional hazard? 1 1 1 149 1 4 11 582
Does Competition under Medicare Prospective Payment Selectively Reduce Expenditures on High-Cost Patients? 0 0 0 0 0 2 12 327
ESTIMATING PERSON‐CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTS 0 0 0 6 0 1 10 52
Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care 0 0 0 29 0 2 14 259
Erratum: Estimating lifetime or episode‐of‐illness costs under censoring 0 0 0 15 0 1 7 53
Estimating lifetime or episode‐of‐illness costs under censoring 0 0 2 23 0 4 21 102
Extended generalized linear models: Simultaneous estimation of flexible link and variance functions 0 0 0 145 0 2 7 427
Generalized modeling approaches to risk adjustment of skewed outcomes data 0 0 0 143 4 7 12 370
HETEROGENEITY IN ACTION: THE ROLE OF PASSIVE PERSONALIZATION IN COMPARATIVE EFFECTIVENESS RESEARCH 0 0 0 2 0 0 8 32
HIGHLIGHTING DIFFERENCES BETWEEN CONDITIONAL AND UNCONDITIONAL QUANTILE REGRESSION APPROACHES THROUGH AN APPLICATION TO ASSESS MEDICATION ADHERENCE 0 0 0 105 0 4 16 304
Implications of spillover effects within the family for medical cost-effectiveness analysis 0 0 0 72 0 3 17 202
Measuring the Value of Pharmaceuticals in the US Health System 0 0 0 5 0 0 1 15
Person-centered treatment (PeT) effects: Individualized treatment effects using instrumental variables 0 0 1 40 0 2 7 159
Personalized Medicine in the Context of Comparative Effectiveness Research 0 0 0 13 0 0 8 110
Private Manufacturers’ Thresholds to Invest in Comparative Effectiveness Trials 0 0 0 5 0 2 7 54
RESPONSE TO EPSTEIN'S COMMENT ON “HETEROGENEITY IN ACTION” 0 0 0 1 0 12 16 34
Scale of interest versus scale of estimation: comparing alternative estimators for the incremental costs of a comorbidity 0 1 1 53 0 3 7 224
The impact of comparative effectiveness research on health and health care spending 0 0 0 35 0 6 15 290
Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling 3 9 19 942 7 22 104 2,809
Welfare implications of learning through solicitation versus diversification in health care 0 0 0 2 0 2 9 43
Total Journal Articles 4 11 24 1,788 12 80 315 6,478


Software Item File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
IVCHECK: Stata module to choose between OLS and contaminated IV 0 0 0 28 0 6 19 259
Total Software Items 0 0 0 28 0 6 19 259


Statistics updated 2026-07-10